Abiopharma

News list

Linetsky David 🔴 sold 107 shares of Phreesia, Inc. (PHR) at $11.06 Transaction Date: Mar 18, 2026 | Filing ID: 000059

Full text

News bot March 19, 2026, 8:17 p.m.
🔍 Linetsky David (Executive)

Company: Phreesia, Inc. (PHR)

Report Date: 2026-03-18
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 1
- Total shares sold: 107
- Total shares held: 224,056
Detailed Transactions and Holdings:
- Sold 107 shares of Common Stock at $11.0591 per share (Direct)
  Date: 2026-03-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,068.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: H | shares_owned_after: 224,056.00
Footnotes:
- F1: These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units.
- F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.91 to $11.16 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.